LatchBio

About:

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.

Twitter/X: LatchBio

Top Investors: General Catalyst, Coatue, Caffeinated Capital, Lux Capital, Hummingbird Ventures

Description:

LatchBio develops a data infrastructure intended to build and disseminate the open-source infrastructure of the biocomputing revolution. Founded in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, the company creates open-source machine learning and cloud infrastructure for the next generation of therapeutic discovery, thereby enabling biotech companies to find therapies faster and save on engineering.

Total Funding Amount:

$33.2M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2021-01-01

Contact Email:

contact(AT)latch.bio

Founders:

Alfredo Andere, Kenny Workman, Kyle Giffin

Number of Employees:

11-50

Last Funding Date:

2022-06-02

IPO Status:

Private

Industries: